First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia

被引:78
作者
Wortelboer, E. J. [1 ]
Koster, M. P. H. [2 ]
Cuckle, H. S. [3 ]
Stoutenbeek, Ph [1 ]
Schielen, P. C. J. I. [2 ]
Visser, G. H. A. [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Obstet, Wilhelmina Childrens Hosp, NL-3508 AB Utrecht, Netherlands
[2] Natl Inst Publ Hlth & Environm RIVM, Lab Infect Dis & Perinatal Screening, Bilthoven, Netherlands
[3] Columbia Univ, Dept Obstet & Gynecol, Coll Med, New York, NY USA
关键词
A desintegrin and metalloproteinase 12; first-trimester; placental growth factor; placental protein 13; pre-eclampsia; MATERNAL SERUM; SOLUBLE ENDOGLIN; PREGNANCY; DISINTEGRIN; ADAM12; RISK;
D O I
10.1111/j.1471-0528.2010.02690.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To investigate the predictive value of maternal serum pregnancy-associated plasma protein A (PAPP-A), free beta subunit of human chorionic gonadotrophin (f beta-hCG), placental protein 13 (PP13), placental growth factor (PlGF) and a desintegrin and metalloproteinase 12 (ADAM12), for first-trimester identification of early-onset pre-eclampsia. Design Nested case-control study. Setting Routine first-trimester screening for trisomy 21 in the Netherlands. Population Eighty-eight women who developed pre-eclampsia or haemolysis, elevated liver enzymes, low platelets (HELLP) syndrome before 34 weeks of gestation and 480 controls. Methods PP13, PlGF and ADAM12 were measured in stored first-trimester serum, previously tested for PAPP-A and f beta-hCG. All marker levels were expressed in multiples of the gestation-specific normal median (MoMs). Model predicted detection rates for fixed false-positive rates were obtained for statistically significant markers alone and in combination. Main outcome measures Development of pre-eclampsia or HELLP syndrome. Results PP13 and PlGF were reduced in women with pre-eclampsia, with medians 0.68 MoM and 0.73 MoM respectively (P < 0.0001 for both). PAPP-A was reduced (median 0.82 MoM, P < 0.02) whereas ADAM12 and f beta-hCG did not differ between control women and those with pre-eclampsia. In pre-eclampsia complicated by a small-for-gestational-age fetus, all markers except f beta-hCG had lower values, compared with pregnancies involving fetuses of normal weight. The model-predicted pre-eclampsia detection rate for a combination of PP13 and PlGF was 44% and 54%, respectively, for a fixed 5% and 10% false-positive rate. Conclusion This study demonstrates that PP13 and PlGF in the first-trimester might be promising markers in risk assessment for early pre-eclampsia/HELLP syndrome but for an adequate screening test additional characteristics are necessary.
引用
收藏
页码:1384 / 1389
页数:6
相关论文
共 19 条
[1]   Maternal serum placental growth factor at 11+0 to 13+6 weeks of gestation in the prediction of pre-eclampsia [J].
Akolekar, R. ;
Zaragoza, E. ;
Poon, L. C. Y. ;
Pepes, S. ;
Nicolaides, K. H. .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2008, 32 (06) :732-739
[2]   The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) [J].
Brown, MA ;
Lindheimer, MD ;
de Swiet, M ;
Van Assche, A ;
Moutquin, JM .
HYPERTENSION IN PREGNANCY, 2001, 20 (01) :IX-XIV
[3]   Placental protein 13 (PP-13): Effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies [J].
Burger, O ;
Pick, E ;
Zwickel, J ;
Klayman, M ;
Meiri, H ;
Slotky, R ;
Mandel, S ;
Rabinovitch, L ;
Paltieli, Y ;
Admon, A ;
Gonen, R .
PLACENTA, 2004, 25 (07) :608-622
[4]   First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction [J].
Chafetz, Ilana ;
Kuhnreich, Ido ;
Sammar, Marei ;
Tal, Yossi ;
Gibor, Yair ;
Meiri, Hamutal ;
Cuckle, Howard ;
Wolf, Myles .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 197 (01) :35.e1-35.e7
[5]  
CUCKLE H, 2004, GENETIC DISORDERS FE, P795
[6]  
Cuckle H, 2000, ANTENATAL NEONATAL S, V2nd, P3
[7]   The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age [J].
Erez, Offer ;
Romero, Roberto ;
Espinoza, Jimmy ;
Fu, Wenjiang ;
Todem, David ;
Kusanovic, Juan Pedro ;
Gotsch, Francesca ;
Edwin, Samuel ;
Nien, Jyh Kae ;
Chaiworapongsa, Tinnakorn ;
Mittal, Pooja ;
Mazaki-Tovi, Shali ;
Than, Nandor Gabor ;
Gomez, Ricardo ;
Hassan, Sonia S. .
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2008, 21 (05) :279-287
[8]  
Kloosterman G J., 1970, Int J Gynecol Obstet, V8, P895, DOI [DOI 10.1002/J.1879-3479.1970.TB00313.X, 10.1002/j.1879-3479.1970.tb00313.x]
[9]   Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia [J].
Laigaard, J ;
Sorensen, T ;
Placing, S ;
Holck, P ;
Fröhlich, C ;
Wojdemann, KR ;
Sundberg, K ;
Shalmi, AC ;
Tabor, A ;
Norgaard-Pedersen, B ;
Ottesen, B ;
Christiansen, M ;
Wewer, UM .
OBSTETRICS AND GYNECOLOGY, 2005, 106 (01) :144-149
[10]   Soluble endoglin and other circulating antiangiogenic factors in preeclampsia [J].
Levine, Richard J. ;
Lam, Chun ;
Qian, Cong ;
Yu, Kai F. ;
Maynard, Sharon E. ;
Sachs, Benjamin P. ;
Sibai, Baha M. ;
Epstein, Franklin H. ;
Romero, Roberto ;
Thadhani, Ravi ;
Karumanchi, S. Ananth .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (10) :992-1005